Bristol-Myers Squibb Foundation's Together on Diabetes® Initiative Marks First Anniversary

Bristol-Myers SquibbThe Bristol-Myers Squibb Foundation today marked World Diabetes Day and the first anniversary of its Together on Diabetes® initiative by awarding eight grants totaling $18.4 million to help communities and populations disproportionately affected by type 2 diabetes. The grants will help develop effective, comprehensive solutions that integrate public health, health care services, community supportive services and the strengths of the communities in order to improve health outcomes and reduce disease burden.

Together on Diabetes: Communities Uniting to Meet America's Diabetes Challenge® is a five-year, $100 million initiative to improve health outcomes for American adults living with type 2 diabetes. Together on Diabetes® focuses on strengthening patient self-management and mobilizing community-based supportive services to help adults disproportionately affected by type 2 diabetes, consistent with the Bristol-Myers Squibb Foundation's mission to reduce global health disparities.

The eight grants announced today focus on communities or populations with high prevalence and burden of type 2 diabetes: Native Americans, Appalachia, the Mississippi Delta region, urban and rural poor, people who are food insecure and people who suffer from both depression and diabetes.

"Type 2 diabetes is continuing to grow year to year in the U.S. despite significant prevention and control efforts," says John Damonti, president of the Bristol-Myers Squibb Foundation. "The creative projects of our partners are challenging and expanding current thinking and laying important groundwork for more comprehensive and impactful diabetes control efforts going forward."

The following organizations received Together on Diabetes® grants:

  • Duke University Medical Center and the Durham County (N.C.) Department of Health and Human Services will receive $6.25 million over five years to develop, pilot and implement a series of community-based interventions designed to improve diabetes self-management, health outcomes and quality of life for diagnosed and undiagnosed adults with type 2 diabetes in the county.
  • Feeding America,in partnership with the Food Bank of Corpus Christi, the Mid-Ohio Foodbank, and the Redwood Empire Food Bank, will receive $3.1 million over three years to create and pilot food bank-health center partnerships that will provide diabetes screening, care coordination, nutrition and disease education, and healthy foods to adults who are living with type 2 diabetes and are food insecure.
  • The Camden (N.J.) Coalition of Healthcare Providers and the Cooper Foundation will receive $3.45 million over five years to strengthen community-based components of its Camden Citywide Diabetes Collaborative care model by focusing on patient self-management, education and support, care coordination, food access and physical activity programs, and behavioral health and community engagement activities in order to bend the curve of the diabetes burden and health care costs in the city.
  • Marshall University Center for Rural Health, in partnership with the U.S. Centers for Disease Control and Prevention and the Appalachian Regional Commission, will receive $2.61 million over five years to build the capacity of 10 community diabetes coalitions to implement evidence-based programs that support long-term behavior change and improve the health of people living with type 2 diabetes.
  • Mississippi Public Health Institute, in partnership with the Mississippi Department of Health, University of Mississippi Medical Center and the Mississippi Division of Medicaid, will receive $504,000 to develop a coordinated, evidence-based, community approach to systematically lower the incidence and severity of diabetes in 18 Delta Region counties by integrating existing medical and non-medical systems of care, supporting the creation of patient-centered medical homes and developing policies that positively impact environmental and social determinants of health related to 2 diabetes.
  • National Network of Public Health Institutes (NNPHI) will receive $180,144 to develop and host a two-day summit in the first quarter of 2012 for Together on Diabetes® grantees, support the Learning Collaboratives for the grantees, and strengthen relationships between Together on Diabetes® grantees and the broader public health practice community.
  • Riverview Medical Center Foundation will receive $50,856 to pilot a modified Wellness Recovery Action Plan model for type 2 diabetes patients who also are suffering from or at risk of developing depression, a common co-morbidity of diabetes.

In addition, Together on Diabetes® will partner with the Johns Hopkins Center for American Indian Health to pioneer intergenerational, family- and community-focused interventions for type 2 diabetes in four tribal communities in the Southwestern United States. Johns Hopkins will receive $2.25 million over two years to adapt a family health coach model to address diabetes prevention and care, screening and diagnosis, healthy lifestyle behavior change, and patient/family self-management. American Indians and Alaska natives suffer the highest rates of type 2 diabetes in the nation - as high as one in three in the Navajo and Apache communities this partnership will target.

"Diabetes, which has become a leading cause of morbidity around the world, affects Native American populations at disproportionately high rates. There is an urgent need to investigate innovative, community-driven ways to prevent and treat diabetes," says Mathuram Santosham, M.D., M.P.H., director of the Center for American Indian Health and a professor in the departments of international health and pediatrics at Johns Hopkins' Bloomberg School of Public Health in Baltimore, Maryland. "In the past century, research conducted in collaboration with Native American populations has led to medical interventions that have saved millions of lives around the world," adds Dr. Santosham. "I believe that Native American populations will once again pave the way to groundbreaking research to tackle the global burden from this dreadful disease."

Together on Diabetes® also today issued its first annual report, which profiles the projects of its national, community, government and academic partners. Together on Diabetes® has awarded 17 grants totaling $32.57 million since its launch on World Diabetes Day last year.

About the Bristol-Myers Squibb Foundation
The Bristol-Myers Squibb Foundation is an independent 501(c)(3) charitable organization whose mission is to reduce health disparities and improve health outcomes around the world for patients disproportionately affected by serious disease.

Most Popular Now

Sanofi to acquire Ablynx for €3.9 Billion

Sanofi and Ablynx, a biopharmaceutical company engaged in the discovery and development of Nanobodies®, entered into a definitive agreement under which Sanofi will offer ...

In wine, there's health: Low levels of alcohol goo…

While a couple of glasses of wine can help clear the mind after a busy day, new research shows that it may actually help clean the mind as well. The new study, which appe...

Repurposed drug found to be effective against Zika…

In both cell cultures and mouse models, a drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus - and blocked transmiss...

More stroke patients may receive crucial treatment…

More patients could be eligible for critical treatments to remove or dissolve blood clots that cause strokes, according to a new treatment guideline issued by the America...

Interim publications of randomized trials make new…

Early results from randomized trials are sometimes published before the trial is completed. The results of such interim publications may generate a great deal of interest...

Drug trial protocol redactions by industry sponsor…

New research published by the Journal of the Royal Society of Medicine exposes the extent of redactions in protocols for industry-sponsored randomised drug trials. Trial ...

Advanced Accelerator Applications receives FDA ap…

Novartis AG (NYSE: NVS) announced that Advanced Accelerator Applications, a subsidiary of Novartis Groupe S.A., has received US Food and Drug Administration (FDA) approva...

Blood vessel-on-a-chips show anti-cancer drug effe…

Researchers at the Institute of Industrial Science (IIS), the University of Tokyo, CNRS and INSERM, report a new organ-on-a-chip technology for the study of blood vessel ...

Roche reports good results in 2017

In 2017, Group sales rose 5% to CHF 53.3 billion. Core operating profit grew 3% and Core EPS increased 5%, reflecting the good underlying business performance. On an IFRS...

FDA approves new treatment for certain digestive t…

The U.S. Food and Drug Administration today approved Lutathera (lutetium Lu 177 dotatate) for the treatment of a type of cancer that affects the pancreas or gastrointesti...

Cells of 3 advanced cancers die with drug-like com…

Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggres...

Pfizer announces positive top-line results for pot…

Pfizer Inc. has announced that REFLECTIONS B3281006, a comparative safety and efficacy study of PF-05280586 versus MabThera® (rituximab-EU), met its primary endpoint. PF-...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]